BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 981126)

  • 21. [Treatment of bronchial asthma and bronchitis with mucolytic drugs].
    Chalon Z; Gruszecki J; Hadydoń B
    Pol Tyg Lek; 1966 Jul; 21(27):1040-2. PubMed ID: 5925941
    [No Abstract]   [Full Text] [Related]  

  • 22. A simple method for the determination of the thread-forming property of tracheobronchial secretions.
    Iravani J; Melville GN
    Respiration; 1976; 33(4):289-93. PubMed ID: 7008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental studies on bronchial secretion. Therapeutical aspects of pathological bronchial secretion.
    Simonsson BG
    Scand J Respir Dis Suppl; 1974; 90():1-89. PubMed ID: 4618374
    [No Abstract]   [Full Text] [Related]  

  • 24. Mucoactive agents for airway mucus hypersecretory diseases.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Physicochemical characteristics of the tracheobronchial mucous secretion of lambs. Modification by a new mucolytic agent (Brovanexine UR-389)].
    Garcia-Rafanell J; Lleonart F
    Therapie; 1976; 31(4):483-90. PubMed ID: 12589
    [No Abstract]   [Full Text] [Related]  

  • 26. [Advantages of mucolytic treatment in bronchitis and bronchial asthma in children].
    Hadydoń B; Chalon Z; Gruszecki J
    Pediatr Pol; 1966 Oct; 41(10):1177-80. PubMed ID: 5977179
    [No Abstract]   [Full Text] [Related]  

  • 27. [Drug therapy of bronchosecretolytic disorders].
    Schmidt OP
    Med Klin; 1977 Feb; 72(5):145-60. PubMed ID: 321928
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacokinetics of Sobrerol in chronic bronchitis. Comparison of serum and bronchial mucus levels.
    Braga PC; De Angelis L; Bossi R; Scaglione F; Scarpazza G; Allegra L; Fraschini F
    Eur J Clin Pharmacol; 1983; 24(2):209-15. PubMed ID: 6840169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mucolytic bisolven (further experiences in the treatment of chronic bronchitis and bronchial asthma)].
    Beritić T
    Lijec Vjesn; 1970; 91(11):1200-2. PubMed ID: 5200810
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative action of reducing agents on fibrillar human bronchial mucus under dissociating and non-dissociating conditions.
    Houdret N; Le Treut A; Lhermitte M; Lamblin G; Degand P; Roussel P
    Biochim Biophys Acta; 1981 May; 668(3):413-9. PubMed ID: 7236718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Proof of eftapan in comparison to bromhexine in children in ambulatory care].
    Bauer C
    Fortschr Med; 1981 Nov; 99(42):1769-72. PubMed ID: 7030893
    [No Abstract]   [Full Text] [Related]  

  • 32. Mucoactive drugs in the management of chronic obstructive pulmonary disease.
    Del Donno M; Olivieri D
    Monaldi Arch Chest Dis; 1998 Dec; 53(6):714-9. PubMed ID: 10063352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathophysiology of chronic, bronchial hypersecretion (author's transl)].
    Puchelle E; Girard F; Polu JM; Aug F; Sadoul P
    Pathol Biol (Paris); 1978 Oct; 26(7):441-51. PubMed ID: 372900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical use of eprazinon-dihydrochloride (Eftapan)].
    Opl G
    Fortschr Med; 1978 Jan; 96(2):79-80. PubMed ID: 620966
    [No Abstract]   [Full Text] [Related]  

  • 35. [Anomalies of mucus and bronchial pathology in adults].
    Polu JM; Delorme N
    Rev Mal Respir; 1989; 6(6):493-9. PubMed ID: 2690213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro and in vivo effect of various substances on the viscosity of sputum from patients with cystic fibrosis].
    Mastella G; Marcer V; Battaglino G
    Fracastoro; 1970; 63(3):479-507. PubMed ID: 5517025
    [No Abstract]   [Full Text] [Related]  

  • 37. [The mucolytic effect of Mesna].
    Bürgi H
    Anaesthesist; 1974 Sep; 23(9):394-7. PubMed ID: 4376339
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of beta-mimetics on bronchial mucus transport].
    Vastag E; Zsámboki G
    Orv Hetil; 1985 Feb; 126(6):323-6. PubMed ID: 2983286
    [No Abstract]   [Full Text] [Related]  

  • 39. [The use of expectorant agents].
    Galsanov Shch B
    Sov Med; 1987; (12):100-5. PubMed ID: 3328304
    [No Abstract]   [Full Text] [Related]  

  • 40. Mucus and mucins.
    Rubin BK
    Otolaryngol Clin North Am; 2010 Feb; 43(1):27-34, vii-viii. PubMed ID: 20172254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.